Oslo, Norway, 10 October 2017

Vistin Pharma ASA (OSE: VISTIN), please find attached the call for the extraordinary general meeting in Vistin Pharma, to be held on 2 November at 10:00 CET at Østensjøveien 27, Oslo. The formal call has been sent to all shareholders registered in the Norwegian Central Security Depository (VPS).

The complete set of documents relating to the general meeting will be made available on www.vistin.com/investors/category455.html.

For further information, please contact:

Gunnar Manum
+47 95 17 91 90

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.